Freddy Frischknecht

@freddyfrischknecht.bsky.social

Cell biologist working on malaria parasites and interested in host pathogen interactions, imaging, teaching, space exploration, gardening.

✨ One year on, we honor Spencer Shorte. On Jan 28, 2026, Institut Pasteur paid tribute to a visionary scientist and human leader. His legacy lives on through the PPU–Research & Technology track, uniting research & innovation as he envisioned. Inspiring future generations.

Bild

Join us (again) for another fantastic BioMalPar meeting @embl.org and also a great pre-meeting @ciid-heidelberg.bsky.social

EMBL Events@events.embl.org · 9mo ago

Do you want to join a community working to reduce the devastating toll of #malaria by pushing forward new ideas, innovations, and strategies? 🦟 🧬 Registration is now open for #EMBLMalaria: https://s.embl.org/bmp26-01-bl ✍️ Submit your abstract by 18 Feb 🗓️ 27 – 29 May 2026 #BioMalPar

Beautiful beasts (2): Thanks Ian for allowing us to help a little to help you figuring out how B-cells help T-cells. What a spectacular cover coloured by #micronaut Martin Oeggerli.

Bild
Science Magazine@science.org · 10mo ago

A new #ScienceImmunology study in mice provides insight into why malaria vaccines that contain the whole Plasmodium parasite may have limited efficacy in humans who live in endemic regions. https://scim.ag/4nONXn9

Curious about how antibodies can target Plasmodium sporozoites? Very happy to see this review out, it means a lot to me to finish my PhD research topic with a nice overview of what is known about how anti-CSP Abs neutralize the parasite in the mammalian host.

Trends in Parasitology@cp-trendsparasitol.bsky.social · 12mo ago

New Review alert! Tissue-dependent protection mechanisms of #antibodies targeting #Plasmodium #sporozoites, authored by @maguirreb.bsky.social & Rogerio Amino. #malaria #circumsporozoiteprotein #CSP @pasteur.fr@upcite.bsky.social authors.elsevier.com/a/1lhKa5Eb1x...

The SynthImmune project by Heidelberg University& partner institutes advances a "bottom-up" synthetic biology approach to immunotherapies. Hoping they do well in the German government's Excellence Strategy—anticipating the announcement on 22 May. Perspective article: www.nature.com/articles/s41...

Bottom-up synthetic immunology - Nature Nanotechnology

This Perspective highlights bottom-up molecular engineering and modular nanobiotechnological approaches for developing effective immunotherapeutics and their potential in personalized medicine.

nature.com